OECD Figures Show Türkiye’s Health System Running Close to Its Limits

A System Defined by Trade-Offs, Not Extremes

The latest Health at a Glance study by the Organisation for Economic Co-operation and Development offers no easy comfort for Türkiye’s health system. Rather than a story of clear progress or clear failure, the data exposes a set of unresolved structural contradictions. Strong performance on access and cost control sits alongside chronic underinvestment, workforce shortages, and uneven health outcomes. Read as a whole, the figures suggest not a system in collapse, but one operating close to its limits—efficient by necessity, resilient in parts, yet increasingly constrained by the very choices that made it affordable.

OECD’s Health at a Glance report forms the basis of the analysis.

Delivering with Less: The Spending Constraint

One of the clearest signals in the OECD data concerns spending. Among the 38 OECD member countries, Türkiye ranks within the lowest five in total health expenditure as a share of GDP. While the OECD average has stabilised around 9 to 10 percent of national income, Türkiye continues to allocate roughly half that level to health. This is not a temporary deviation. The data shows a persistent pattern over time, pointing to a structural policy stance rather than cyclical budget tightening.

Access Without Expansion

What complicates this picture is that low spending has not translated into weak access. On the contrary, Türkiye performs above the OECD average on several access and service delivery indicators, suggesting that the system has learned how to stretch limited resources. Broad coverage, relatively easy entry into care, and widespread service availability remain defining features.

Efficiency as Policy, Not Exception

Cost containment is central to this outcome. The extensive use of generic medicines, well above the OECD average, helps keep pharmaceutical spending under control and limits the financial burden on households. Efficiency, rather than expansion, appears to be the organising principle of the system.

A Different Baseline on Alcohol Consumption

Another area where Türkiye diverges sharply from the OECD norm is alcohol consumption. As one of the core behavioural risk factors tracked in the report, alcohol places sustained pressure on many health systems. Türkiye, however, remains among the countries with the lowest recorded per-capita alcohol consumption, operating on a baseline far below the OECD average. The report frames this not as a short-term policy outcome, but as a structural feature shaped by long-standing social norms and regulatory choices. In comparative terms, this reduces pressure linked to preventable chronic disease and injury—one of the few areas where Türkiye does not merely underperform or outperform peers, but follows a fundamentally different trajectory.

Where the Model Starts to Strain

Yet the limits of the model become visible when system capacity is examined. Despite relatively strong access outcomes, health workforce indicators lag behind OECD norms. Physician and nurse densities remain well below average, signalling that services are being delivered with constrained human resources. This gap mirrors the low level of overall spending and raises questions about sustainability.

When Access Does Not Equal Outcomes

Health outcomes and risk factors reinforce this mixed picture. Türkiye performs above the OECD average on only a small number of population health indicators. Progress is evident, but uneven, suggesting that access and efficiency have not consistently translated into stronger long-term outcomes. Prevention, lifestyle-related risks, and chronic disease management remain areas of vulnerability.

Running Close to the Limits

Taken together, the OECD data points to a system that has prioritised coverage and cost control, but not without trade-offs. While access has been preserved under tight fiscal constraints, low spending levels increasingly translate into pressure points—most visibly in workforce shortages, limited capacity for prevention, and uneven outcomes. Efficiency has carried the system far, but the data suggests it may no longer be sufficient on its own. Without stronger investment in human resources, preventive care, and system resilience, Türkiye risks locking in a model that delivers broadly, yet struggles to deepen quality and durability over time.

*** This analysis is based on the OECD’s Health at a Glance 2025 report. The full report is available here.